Total Payments
$22,335
2022 Payments
$21.38
Companies
11
Transactions
47
Medicare Patients
958
Medicare Billing
$113,667
Payment Breakdown by Category
Other$19,110 (85.6%)
Travel$2,322 (10.4%)
Food & Beverage$686.67 (3.1%)
Gifts$159.96 (0.7%)
Education$56.70 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,110 | 6 | 85.6% |
| Travel and Lodging | $2,322 | 11 | 10.4% |
| Food and Beverage | $686.67 | 20 | 3.1% |
| Gift | $159.96 | 3 | 0.7% |
| Education | $56.70 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $21,886 | 22 | $0 (2019) |
| Braintree Laboratories, Inc. | $159.96 | 3 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $136.42 | 13 | $0 (2019) |
| Pacira Pharmaceuticals Incorporated | $36.99 | 2 | $0 (2019) |
| Boston Scientific Corporation | $21.38 | 1 | $0 (2022) |
| Shire North American Group Inc | $19.15 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $18.08 | 1 | $0 (2018) |
| Covidien LP | $16.61 | 1 | $0 (2018) |
| Baudax Bio Inc. | $15.59 | 1 | $0 (2020) |
| Teleflex Medical Incorporated | $12.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $21.38 | 1 | Boston Scientific Corporation ($21.38) |
| 2020 | $28.16 | 2 | Baudax Bio Inc. ($15.59) |
| 2019 | $3,623 | 8 | Merck Sharp & Dohme Corporation ($3,437) |
| 2018 | $6,860 | 8 | Merck Sharp & Dohme Corporation ($6,825) |
| 2017 | $11,803 | 28 | Merck Sharp & Dohme Corporation ($11,624) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2022 | Boston Scientific Corporation | General - GI Dilatation (Device) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: General - GI Dilatation_ENDO | ||||||
| 10/16/2020 | Baudax Bio Inc. | ANJESO (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Pain Management | ||||||
| 01/30/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $12.57 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 06/27/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/09/2019 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/09/2019 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/02/2019 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Food and Beverage | In-kind items and services | $102.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2019 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Gift | In-kind items and services | $53.32 | General |
| Category: GI COLON PREP | ||||||
| 03/19/2019 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Gift | In-kind items and services | $53.32 | General |
| Category: GI COLON PREP | ||||||
| 03/19/2019 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Gift | In-kind items and services | $53.32 | General |
| Category: GI COLON PREP | ||||||
| 02/21/2019 | Mallinckrodt Enterprises LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: ACUTE CARE | ||||||
| 10/30/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.08 | General |
| 07/23/2018 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/23/2018 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/16/2018 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Food and Beverage | In-kind items and services | $102.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/13/2018 | Covidien LP | Smart Pill (Device) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: GI Solutions | ||||||
| 06/11/2018 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/11/2018 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/06/2018 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Food and Beverage | In-kind items and services | $52.56 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2017 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2017 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/20/2017 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Travel and Lodging | In-kind items and services | $392.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/20/2017 | Merck Sharp & Dohme Corporation | ENTEREG (Drug) | Travel and Lodging | In-kind items and services | $258.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/19/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ACUTE CARE | ||||||
| 09/07/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: ACUTE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 208 | 249 | $108,039 | $28,005 |
| 2022 | 12 | 306 | 347 | $144,734 | $36,672 |
| 2021 | 7 | 211 | 245 | $96,319 | $25,312 |
| 2020 | 11 | 233 | 258 | $87,222 | $23,677 |
Total Patients
958
Total Services
1,099
Medicare Billing
$113,667
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 23 | 51 | $52,479 | $11,748 | 22.4% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 45 | 45 | $14,175 | $4,628 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 58 | $10,556 | $4,121 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $8,976 | $2,779 | 31.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 51 | 51 | $9,588 | $2,712 | 28.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $12,265 | $2,018 | 16.5% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 16 | 37 | $38,073 | $8,605 | 22.6% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 59 | 59 | $18,585 | $6,315 | 34.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 75 | 75 | $14,100 | $3,953 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 51 | $9,282 | $3,519 | 37.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 15 | 15 | $22,920 | $3,209 | 14.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $7,210 | $2,643 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $7,888 | $2,331 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $3,824 | $1,718 | 44.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 12 | $5,856 | $1,676 | 28.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $13,656 | $1,556 | 11.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 20 | $2,020 | $653.87 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,320 | $493.00 | 37.3% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2021 | 14 | 26 | $26,754 | $6,370 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 71 | $12,922 | $4,701 | 36.4% |
| 46600 | Diagnostic examination of the anus using an endoscope | Office | 2021 | 37 | 37 | $11,655 | $3,484 | 29.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $9,520 | $3,055 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 17 | $8,296 | $2,914 | 35.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 12 | 12 | $18,336 | $2,455 | 13.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 47 | 47 | $8,836 | $2,334 | 26.4% |
About Dr. Scott Thornton, MD
Dr. Scott Thornton, MD is a Colon & Rectal Surgery healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750351995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Thornton, MD has received a total of $22,335 in payments from pharmaceutical and medical device companies, with $21.38 received in 2022. These payments were reported across 47 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,110).
As a Medicare-enrolled provider, Thornton has provided services to 958 Medicare beneficiaries, totaling 1,099 services with total Medicare billing of $113,667. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Colon & Rectal Surgery
- Location Fairfield, CT
- Active Since 01/23/2006
- Last Updated 05/01/2012
- Taxonomy Code 208C00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750351995
Products in Payments
- ENTEREG (Drug) $21,886
- SUPREP BOWEL PREP (Drug) $159.96
- OFIRMEV (Drug) $136.42
- EXPAREL (Drug) $36.99
- General - GI Dilatation (Device) $21.38
- GATTEX (Drug) $19.15
- Smart Pill (Device) $16.61
- ANJESO (Drug) $15.59
- Access Solutions: Weck brand (Device) $12.74
- ANDEXXA (Biological) $12.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.